Malvern Bncp Cmn Stk (MLVF) 16.71 $MLVF Malvern Bancorp,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Malvern Bncp Cmn Stk (MLVF) 16.71 $MLVF

Malvern Bancorp, Inc. Reports Net Income of $1.6 million, or $0.25 per Share, for the Third quarter of Fiscal 2016, Representing a 31.9% Increase over the Third quarter of Fiscal 2015
GlobeNewswire - Thu Jul 28, 6:05AM CDT
Malvern Bancorp, Inc. (NASDAQ:MLVF) (the "Company", parent company of Malvern Federal Savings Bank ("Malvern" or the "Bank", today reported operating results for the third fiscal quarter ended June 30, 2016. Net income amounted to $1.6 million, or $0.25 per share, for the quarter ended June 30, 2016, an increase of $384,000, or 31.9 percent, as compared with the net income of $1.2 million, or $0.19 per share, for the quarter ended June 30, 2015.
MLVF: 16.71 (+0.21)

Malvern Bancorp posts 2Q profit
Automated Insights - Fri Apr 29, 6:24PM CDT
PAOLI, Pa. (AP) _ Malvern Bancorp Inc. (MLVF) on Friday reported fiscal second-quarter earnings of $1.3 million.
MLVF: 16.71 (+0.21)

Malvern Bancorp, Inc. Reports Net Income of $1.3 million, or $0.20 per Share, for the Second Quarter of Fiscal 2016, Representing a 25.6% Increase over the Second Quarter of Fiscal 2015
GlobeNewswire - Fri Apr 29, 6:06AM CDT
Malvern Bancorp, Inc. (NASDAQ:MLVF) (the "Company", parent company of Malvern Federal Savings Bank ("Malvern" or the "Bank", today reported operating results for the second fiscal quarter ended March 31, 2016. Net income amounted to $1.3 million, or $0.20 per share, for the quarter ended March 31, 2016, an increase of $258,000, or 25.6 percent, as compared with the net income of $1.0 million, or $0.16 per share, for the quarter ended March 31, 2015.
MLVF: 16.71 (+0.21)

Malvern Federal Savings Bank Names Banking Veteran William J. Boylan Chief Lending Officer
GlobeNewswire - Mon Apr 25, 2:45PM CDT
Malvern Federal Savings Bank ("Malvern), the wholly owned subsidiary of Malvern Bancorp, Inc. (NASDAQ:MLVF), today announced it has appointed banking veteran William J. Boylan as Senior Vice President & Chief Lending Officer. In this role, Boylan will oversee all aspects of Malvern's lending business in Pennsylvania and New Jersey. Previously, Boylan had served as Senior Vice President and Chief Lending Officer of Malvern's New Jersey Division, headquartered in Morristown, New Jersey.
MLVF: 16.71 (+0.21)

Malvern Bancorp Reports Resignations of Two Board Members
GlobeNewswire - Wed Feb 03, 2:15PM CST
Malvern Bancorp, Inc. (Nasdaq:MLVF), (the "Company", parent company of Malvern Federal Savings Bank (the "Bank", announced today that F.Claire Hughes, Jr. and Robert Willson have submitted their resignations from the Boards of Directors of the Company and the Bank, effective February 14 and February 17, 2016 respectively, and that they are not seeking re-election at the shareholders meeting on February 17, 2016.
MLVF: 16.71 (+0.21)

Malvern Bancorp, Inc. Announces Termination of Formal Agreement Between Malvern Federal Saving Bank and the Comptroller of the Currency
GlobeNewswire - Wed Jan 27, 6:16AM CST
Malvern Federal Savings Bank, (the "Bank" the wholly owned subsidiary of Malvern Bancorp, Inc. (NASDAQ:MLVF) (the "Company", was informed by its primary regulator, the Office of the Comptroller of the Currency (the "OCC", that the formal written agreement between the Bank and the OCC, dated October 7, 2014 (the "Formal Agreement", was terminated effective January 21, 2016. As a result of the OCC's action, the Bank is no longer considered to be in "troubled condition."
MLVF: 16.71 (+0.21)

Malvern Bancorp, Inc. Reports Net Income of $1.3 Million or $0.21 per Share for the First Quarter of Fiscal 2016, Representing a 318.7% Increase Over the First Quarter of Fiscal 2015
GlobeNewswire - Wed Jan 27, 6:00AM CST
Malvern Bancorp, Inc. (NASDAQ:MLVF) (the "Company", parent company of Malvern Federal Savings Bank ("Malvern" or the "Bank", today reported operating results for the first fiscal quarter ended December 31, 2015. Net income amounted to $1.3 million, or $0.21 per share, for the quarter ended December 31, 2015, an increase of $1.0 million or 318.7 percent as compared with the net income of $321,000, or $0.05 per share, for the quarter ended December 31, 2014.
MLVF: 16.71 (+0.21)

Malvern Federal Savings Bank Appoints Karen Walter Chief Operating Officer
GlobeNewswire - Tue Jan 26, 2:45PM CST
Malvern Federal Savings Bank, ("Malvern" the wholly owned subsidiary of Malvern Bancorp, Inc. (NASDAQ:MLVF), today announced the appointment of Karen Walter as Chief Operating Officer.
MLVF: 16.71 (+0.21)

Malvern to Madison Avenue: Malvern Federal Savings Plans to Open Branch Office in Morristown, N.J.
GlobeNewswire - Mon Jan 25, 2:45PM CST
Malvern Federal Savings Bank, ("Malvern" the wholly owned subsidiary of Malvern Bancorp, Inc. (NASDAQ:MLVF), today announced that it has filed an application with the Office of the Comptroller of the Currency for approval to open a full-service branch in Morristown, N.J.
MLVF: 16.71 (+0.21)

Malvern Federal Savings Fills Three Key Executive Positions
GlobeNewswire - Wed Jan 13, 9:00AM CST
Malvern Federal Savings Bank, the wholly owned subsidiary of Malvern Bancorp, Inc. (NASDAQ:MLVF), today announced the appointments of three experienced banking executives to key lending and business development positions. Mark Cohen was appointed Senior Vice President, Senior Commercial Lender; James Czuba was named Vice President, Director of Residential & Consumer Lending; and Ann Foanio was appointed Assistant Vice President, Business Development Officer.
MLVF: 16.71 (+0.21)

Malvern Federal Savings Bank Appoints Kim Arnold Vice President, Business Development and Private Banking
GlobeNewswire - Mon Jan 11, 4:06PM CST
Malvern Federal Savings Bank, the wholly owned subsidiary of Malvern Bancorp, Inc. (NASDAQ:MLVF), today announced the appointment of Kim Arnold as vice president, business development & private banking. In this role, she will provide credit and wealth management solutions for high net worth individuals, helping them to preserve liquidity and achieve their investment goals.
MLVF: 16.71 (+0.21)

Malvern Federal Savings Bank Appoints Stacy Valent Senior Vice President, Chief Credit Officer
GlobeNewswire - Thu Jan 07, 3:30PM CST
Malvern Federal Savings Bank, ("Malvern" the wholly owned subsidiary of Malvern Bancorp, Inc. (NASDAQ:MLVF), today announced the appointment of Stacy L. Valent as the Bank's Senior Vice President, Chief Credit Officer. In this role, she is responsible for the day-to-day oversight and administration of the Bank's loan portfolio, including managing the loan review, compliance, collections and credit analysis functions.
MLVF: 16.71 (+0.21)

Malvern Federal Savings Bank Continues to Expand Its Wealth Management Offering; Appoints Sara "Sally" Lawson as Senior Investment Adviser
GlobeNewswire - Tue Jan 05, 3:15PM CST
Malvern Federal Savings Bank, ("Malvern" the wholly owned subsidiary of Malvern Bancorp, Inc. (NASDAQ:MLVF), today announced the appointment of Sally Lawson as senior investment adviser for the Bank as part of her role as a Managing Director /Senior Investment Adviser with Bell Rock Capital, LLC, ("Bell Rock" the strategic partner of Malvern's. In hiring Lawson, Malvern continues the expansion of its wealth management offerings. Sally will be based out of the Bank's new Villanova location as well as the Bank's New Jersey private banking offices to be located in Morristown. This addition comes as part of the expansion of the strategic partnership announced in 2014 with Bell Rock Capital, an SEC-Registered Investment Adviser firm headquartered in Delaware with satellite offices in New Jersey, Pennsylvania and Florida.
MLVF: 16.71 (+0.21)

Malvern Federal Savings Bank to Open Private Banking Office in Villanova
GlobeNewswire - Mon Jan 04, 3:24PM CST
Malvern Federal Savings Bank, ("Malvern" the wholly owned subsidiary of Malvern Bancorp, Inc. (NASDAQ:MLVF), will open a private banking branch office in Villanova, Pa., at 801 East Lancaster Avenue. The office, at the corner of Route 30 and Route 320/Spring Mill Rd., will offer an array of services including savings, private banking, trust, wealth management and lending services. The branch will be staffed by a registered investment advisor and retail and private banking professionals with years of financial services experience.
MLVF: 16.71 (+0.21)

Malvern Bancorp, Inc. Reports Net Income of $1.2 Million or $0.18 Per Share for the Fourth Quarter of Fiscal 2015, Representing a 296.0% Increase Over the Fourth Quarter of Fiscal 2014
GlobeNewswire - Fri Oct 30, 3:05PM CDT
Malvern Bancorp, Inc. (NASDAQ:MLVF) (the "Company", parent company of Malvern Federal Savings Bank ("MFSB" or the "Bank", today reported operating results for the fourth quarter ended September 30, 2015. Net income amounted to $1.2 million, or $0.18 per share, for the quarter ended September 30, 2015, an increase of $870,000 or 296.0 percent as compared with the net income of $294,000, or $0.05 per share, for the quarter ended September 30, 2014.
MLVF: 16.71 (+0.21)

Malvern Bancorp (MLVF): An Off-the-Radar Potential Winner
Zacks Equity Research - Zacks Investment Research - Thu Sep 03, 7:35AM CDT
One company that looks well positioned for a solid gain, but has been overlooked by investors lately is Malvern Bancorp, the stock of which company has actually seen rising estimates over the past one month
MLVF: 16.71 (+0.21)

Why Malvern Bancorp (MLVF) Stock Might be a Great Pick
Zacks Equity Research - Zacks Investment Research - Fri Aug 28, 7:52AM CDT
Malvern Bancorp is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective
MLVF: 16.71 (+0.21)

Can Malvern Bancorp (MLVF) Run Higher on Strong Earnings Estimate Revisions?
Zacks Equity Research - Zacks Investment Research - Fri Aug 21, 7:40AM CDT
Malvern Bancorp (MLVF) is seeing solid earnings estimate revisions, and the stock price is showing decent short-term momentum as well.
MLVF: 16.71 (+0.21)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading